about
Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancerTargeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transitionPG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma modelRise and fall of an anti-MUC1 specific antibodyPhase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer.Survival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer.Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.GROα overexpression drives cell migration and invasion in triple negative breast cancer cells.Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells.Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis.Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialProspective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.A CXCL1 paracrine network links cancer chemoresistance and metastasisMiR-630 suppresses breast cancer progression by targeting metadherin.Host Cxcr2-dependent regulation of mammary tumor growth and metastasisMiR-654-5p attenuates breast cancer progression by targeting EPSTI1.Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.Treatment options for breast cancer resistant to anthracycline and taxaneWhich patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians.Overcoming drug resistance in patients with metastatic breast cancer.Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.Treatment of metastatic breast cancer: second line and beyond.Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome.Mechanoresponsive stem cells to target cancer metastases through biophysical cues.Breast cancer gene therapy using an adenovirus encoding human IL-2 under control of mammaglobin promoter/enhancer sequences.Nanoparticles for imaging and treatment of metastatic breast cancer.Aggressive treatment for hepatic metastases from breast cancer: results from a single center.Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer.Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.Migration Rate Inhibition of Breast Cancer Cells Treated by Caffeic Acid and Caffeic Acid Phenethyl Ester: An In Vitro Comparison Study.Construction of Human Immune and Naive scFv Libraries.Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.
P2860
Q24628786-0FC70330-14F1-45C3-8FAD-9A5CB7A6C10DQ26745420-ACDED873-1E3D-424F-A0C8-C707129669B3Q27305726-AA0534BC-7F40-4D71-8F62-4948F279E70CQ27327191-A3818793-0DB9-43E8-BE25-C1F0DE9A8206Q28743508-D9971B22-7CC5-4AE1-BDD2-6C991A3F395FQ33408664-7DFBBEF3-3EFF-4DB6-89AD-C48E8C41B133Q33516882-C0E4ACFE-B7DD-4F2C-B941-8FE3DE4298B4Q33643007-DF5E219E-5935-480E-BC02-F5E008B811BBQ33858488-367B4093-9599-4722-AF1A-F2D10F34B78DQ34005315-57C3238D-CF48-4935-902E-ECE636647700Q35090829-E3DFEF06-B20F-4886-BAA0-6EB3D1317EAFQ35507680-E8C321C6-61FD-4FA3-9868-C643B659DF10Q35684496-DDCD191A-F26C-47E9-95B3-C4AFED9659E4Q35788276-166B22B5-31D9-4718-9AA9-B1A18FD0559DQ36322815-EF350F8B-FE51-4785-8378-5F965050B8AFQ36326026-5E1DBB74-BEDC-4ED8-AE2E-90F0067A0E4CQ36482032-955CE1E2-4EB1-482A-83BA-97D6C8251B85Q36738807-4CFD6B3B-6962-4851-B49C-AF3B3FB53166Q36767227-AED0B58D-EA81-4150-84B3-12FBBF310F3EQ36878791-49FEAFE3-4FD9-47E3-B629-E6067059A7BEQ36970516-1228C8F7-7B9B-4825-9B46-1A16DBB59F66Q37207961-719622CF-3C65-4C1F-8E5E-684E41BCA2E9Q37236305-1A33A5D3-6122-4CD8-8AFB-1ADC2D0798E2Q37564485-743042F5-C548-475D-B659-FF037708EB41Q37599077-24F5702E-5F63-4C59-BAB3-EFCD5FA4CDF5Q37659713-18984EF7-E48C-45DC-8F83-FE43A7489DC2Q37802108-5531E9D7-BBA8-4D1F-B102-5329B54DABC2Q37948672-1A6D0AE2-DD94-4E9A-9B44-0D728C8B46E6Q38021354-954DE473-66EA-40DE-BCB1-332E56E151FFQ38162883-9BAE566E-E980-4CEA-91BB-768CA74393EDQ38381907-1FC75C8D-310F-4971-86B9-92F1F04ACD76Q38651379-85798166-B306-4389-B526-57AD3BD0024BQ38772887-B108AFAB-FAE4-485C-ADFB-1A592D1C7A84Q38842983-26C7C4D6-D7F5-4F05-9D43-29FAB17C44D0Q42691061-65A16549-0ACE-4190-9023-50C2E78D31D5Q45952985-27B50E2B-626B-415A-8A96-10BD8788B40CQ47398521-E1DFC236-AD4D-4C45-81F7-1896D1B6DCAEQ47607553-34BBB6D7-405F-4F1A-8BBD-DF94F1F3D87AQ50108558-50FFB961-52DD-4390-9A6E-F8BFF1D56622Q54240368-2AB7DD9A-614C-4FB4-B8BA-D9D3D0262A10
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metastatic breast cancer: the treatment challenge.
@en
Metastatic breast cancer: the treatment challenge.
@nl
type
label
Metastatic breast cancer: the treatment challenge.
@en
Metastatic breast cancer: the treatment challenge.
@nl
prefLabel
Metastatic breast cancer: the treatment challenge.
@en
Metastatic breast cancer: the treatment challenge.
@nl
P356
P1476
Metastatic breast cancer: the treatment challenge.
@en
P2093
Stephen E Jones
P304
P356
10.3816/CBC.2008.N.025
P407
P577
2008-06-01T00:00:00Z